Search Results for: Bowel

TNFα-antagonist use and mucosal inflammation are associated with increased intestinal expression of SARS-CoV-2 host protease TMPRSS2 in patients with inflammatory bowel disease.

TNFα-antagonist use and mucosal inflammation are associated with increased intestinal expression of SARS-CoV-2 host protease TMPRSS2 in patients with inflammatory bowel disease.

Coronavirus Literature
Publication date: Jun 15, 2020 Concepts Keywords Antagonist Inflammatory bowel disease Gastroenterology Inflammation Inflammation Cytokines Inflammatory Bowel Disease Gastrointestinal tract disorders Protease Autoimmune diseases SARS Branches of biology TNF Medicine ... Read more